A pilot study of delayed versus immediate serial casting after botulinum toxin injection for partially reducible spastic equinus

Journal of Pediatric Orthopaedics

Volumn 27, Issue 8, 2007, Pages 882-885

  Newman, Christopher John ^a   Kennedy, Ann ^b   Walsh, Michael ^b   O'Brien, Timothy ^b   Lynch, Bryan ^b   Hensey, Owen ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Central Remedial Clinic Ireland   (Ireland)

Author keywords

Botulinum toxin; Serial casting; Spasticity

Indexed keywords

BOTULINUM TOXIN;

ARTICLE; CAST APPLICATION; CHILD; CLINICAL ARTICLE; CONTRACTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEMIPLEGIA; HUMAN; MALE; MOEBIUS SYNDROME; PES EQUINUS; PRIORITY JOURNAL; SPASTICITY;

BOTULINUM TOXIN TYPE A; CASTS, SURGICAL; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; EQUINUS DEFORMITY; HEMIPLEGIA; HUMANS; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 38349092328     PISSN: 02716798     EISSN: None     Source Type: Journal    
DOI: 10.1097/BPO.0b013e31815b4d7d     Document Type: Article

References (15)

1. Flett PJ. Rehabilitation of spasticity and related problems in childhood cerebral palsy. J Paediatr Child Health. 2003;39:6-14.
2. Boyd RN, Hays RM. Outcome measurement of effectiveness of botulinum toxin type A in children with cerebral palsy: an ICIDH-2 approach. Eur J Neurol. 2001;8:167-177.
3. Corry IS, Cosgrove AP, Duffy CM, et al. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective trial. J Pediatr Orthop. 1998;18(3):304-311.
4. Kay RM, Rethlefsen SA, Fern-Buneo A, et al. Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy. J Bone Joint Surg Am. 2004;86-A(11):2377-2384.
5. Boyd R, Graham H. Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. Eur J Neurol. 1999;6:S23-S35.
6. Fosang AL, Galea MP, McCoy AT, et al. Measures of muscle and joint performance in the lower limb of children with cerebral palsy. Dev Med Child Neurol. 2003;45(10):664-670.
7. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987;67(2):206-207.
8. Ackman JD, Russman BS, Thomas SS, et al. Comparing botulinum toxin Awith casting for treatment of dynamic equinus in children with cerebral palsy. Dev Med Child Neurol. 2005;47(9):620-627.
9. Glanzman AM, Kim H, Swaminathan K, et al. Efficacy of botulinum toxin A, serial casting, and combined treatment for spastic equinus: a retrospective analysis. Dev Med Child Neurol. 2004;46(12):807-811.
10. Desloovere K, Molenaers G, Jonkers I, et al. A randomized study of combined botulinum toxin type A and casting in the ambulant child with cerebral palsy using objective outcome measures. Eur J Neurol. 2001;8:75-87.
11. Eleopra R, Tugnoli V, De Grandis D. The variability in the clinical effect induced by botulinum toxin type A: the role of muscle activity in humans. Mov Disord. 1997;12(1):89-94.
12. Hesse S, Jahnke MT, Luecke D, et al. Short-term electrical stimulation enhances the effectiveness of Botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients. Neurosci Lett. 1995;201(1):37-40.
13. Hesse S, Reiter F, Konrad M, et al. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trial. Clin Rehabil. 1998;12(5):381-388.
14. Hughes R, Whaler B. Influence of nerve-ending activity and of drugs on the rate of paralysis of rat diaphragm preparation by Cl. botulinum type A toxin. J Physiol. 1962;160:221-233.
15. Simpson LL. Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction. J Pharmacol Exp Ther. 1980;212(1):16-21.